MARK A SR PRYGOCKI

CIK 1257544 · President · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$18.86M

Companies

4

Total Filings

42

Lifetime Open-Market Net

-$5.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VRCA Director $5.73 $0 10 2026-06-09
Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Director 5,766 $0.01 $78 $0 2 2022-06-09
Revance Therapeutics, Inc. (RVNC) Delisted Director $3.65 $0 2 2016-05-09
MRX President 304,453 $61.96 $18.86M -$5.67M 27 2012-04-05

Recent Filings · Page 4 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-03-03 MRX Grant (A) +66,108 $0 EDGAR
2010-03-02 MRX Tax (F) −3,913 -$88.0K EDGAR
2010-02-09 MRX Tax (F) −838 -$18.7K EDGAR
2009-07-23 MRX Tax (F) −728 -$11.4K EDGAR
2009-05-19 MRX Mixed +2,000 -$21.9K EDGAR
2009-04-07 MRX Tax (F) −1,325 -$16.2K EDGAR
2009-03-10 MRX Tax (F) −796 -$8.2K EDGAR
2009-03-03 MRX Grant (A) +124,113 $0 EDGAR
2009-02-10 MRX Tax (F) −554 -$6.6K EDGAR
2008-07-23 MRX Tax (F) −475 -$9.2K EDGAR
Showing 3140 of 42
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.